Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Teva
Cantor Fitzgerald
Daiichi Sankyo
AstraZeneca
Mallinckrodt
QuintilesIMS
Julphar
Fuji

Generated: May 27, 2018

DrugPatentWatch Database Preview

CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Codeine Phosphate And Chlorpheniramine Maleate patents expire, and what generic alternatives are available?

Codeine Phosphate And Chlorpheniramine Maleate is a drug marketed by Spriaso Llc and is included in one NDA. There are four patents protecting this drug.

This drug has fifty-eight patent family members in eleven countries.

The generic ingredient in CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; codeine phosphate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; codeine phosphate profile page.

US Patents and Regulatory Information for CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Spriaso Llc CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; codeine phosphate TABLET, EXTENDED RELEASE;ORAL 206323-001 Jun 22, 2015 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for CODEINE PHOSPHATE AND CHLORPHENIRAMINE MALEATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,569,463 Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions ➤ Try a Free Trial
6,294,192 Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents ➤ Try a Free Trial
2,015,224,130 ➤ Try a Free Trial
6,458,383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
QuintilesIMS
US Army
Deloitte
Colorcon
Argus Health
Baxter
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.